403 related articles for article (PubMed ID: 8419644)
1. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
Chang LJ; McNulty E; Martin M
J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
[TBL] [Abstract][Full Text] [Related]
2. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
5. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
6. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
7. Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types.
Ross EK; Buckler-White AJ; Rabson AB; Englund G; Martin MA
J Virol; 1991 Aug; 65(8):4350-8. PubMed ID: 2072454
[TBL] [Abstract][Full Text] [Related]
8. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
9. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
Vlach J; Garcia A; Jacqué JM; Rodriguez MS; Michelson S; Virelizier JL
Virology; 1995 Apr; 208(2):753-61. PubMed ID: 7747447
[TBL] [Abstract][Full Text] [Related]
10. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
[TBL] [Abstract][Full Text] [Related]
11. Transactivation of heterologous promoters by HIV-1 tat.
Han P; Brown R; Barsoum J
Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
[TBL] [Abstract][Full Text] [Related]
12. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.
Berkhout B; Jeang KT
J Virol; 1992 Jan; 66(1):139-49. PubMed ID: 1727476
[TBL] [Abstract][Full Text] [Related]
13. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
Perkins ND; Edwards NL; Duckett CS; Agranoff AB; Schmid RM; Nabel GJ
EMBO J; 1993 Sep; 12(9):3551-8. PubMed ID: 8253080
[TBL] [Abstract][Full Text] [Related]
14. Increased spacing between Sp1 and TATAA renders human immunodeficiency virus type 1 replication defective: implication for Tat function.
Huang LM; Jeang KT
J Virol; 1993 Dec; 67(12):6937-44. PubMed ID: 8230415
[TBL] [Abstract][Full Text] [Related]
15. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
16. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
[TBL] [Abstract][Full Text] [Related]
17. Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.
Lin HC; Bodkin M; Lal RB; Rabson AB
J Virol; 1995 Nov; 69(11):7216-25. PubMed ID: 7474143
[TBL] [Abstract][Full Text] [Related]
18. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
[TBL] [Abstract][Full Text] [Related]
19. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements.
Desai-Yajnik V; Samuels HH
Mol Cell Biol; 1993 Aug; 13(8):5057-69. PubMed ID: 8393143
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
Popik W; Pitha PM
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9573-7. PubMed ID: 1719535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
